VERDOT and GMI Announce New Agency Partnership to Strengthen Bioprocessing and Advance Biopharmaceutical Manufacturing in the United States

Minnesota, USA, [Sep. 15, 2025] – GMI, a trusted provider of laboratory solutions, is pleased to announce a new strategic agency partnership with VERDOT, a French leader in downstream bioprocessing technologies. This agreement represents a major milestone in GMI’s mission to deliver cutting-edge solutions to U.S. laboratories, giving biopharmaceutical manufacturers access to VERDOT’s innovative single-use systems.

Since 1995, GMI has supported the life sciences industry with high-quality laboratory equipment and services, serving academic institutions, research organizations, and industrial clients across the U.S. The company is known for its commitment to customer support, extensive service expertise, and dedication to helping laboratories achieve cost-effective performance.

Through this new partnership, GMI will act as an agent for VERDOT’s single-use FlexiPro™ and conventional MiniPro™ systems, giving U.S. customers access to VERDOT’s proven expertise in GMP purification and downstream processing from pilot through commercial production scales. Together, the two companies will deliver solutions designed to optimize workflows, accelerate development timelines, and increase access to advanced therapies.

Charles Ruban, President and CEO of VERDOT, stated:

“We are thrilled to announce our partnership with GMI. Their expertise in purification equipment, combined with their commitment to quality and customer service in the U.S., makes them the perfect partner for VERDOT. Through this collaboration, we will be able to propose our unique FlexiPro™ Chrom and TFF product lines, renowned for their flexibility and performance, to a broader audience of biotech, CDMO, and biopharma customers. We look forward to achieving great success together.”

Justin Volling, President and CEO of GMI, commented:

“We are delighted to partner with VERDOT, a company that shares GMI’s commitment to exceptional customer experience, sustainability, and uncompromising quality. We are confident that our team’s expertise, experience, and base of loyal customers will help amplify VERDOT’s offering of tailored purification solutions in North America. This partnership is an immensely impactful addition as we continue to deliver unparalleled value to our customers.”

This collaboration combines VERDOT’s decades of experience in downstream purification with GMI’s established U.S. network to provide customers with high-performance, cost-effective purification solutions that drive innovation in biopharmaceutical manufacturing.

About VERDOT

Founded in 1950 and headquartered in Riom, France, VERDOT is a global leader in downstream bioprocessing technology. The company develops innovative purification solutions for the biopharmaceutical industry, including chromatography columns and customized chromatography and tangential flow filtration (TFF) systems. These technologies are critical for the purification, separation, and concentration of biomolecules such as monoclonal antibodies, vaccines, viral vectors (AAV and lentivirus), and mRNA-based therapeutics.

VERDOT partners with biopharma leaders, research organizations, early-stage biotech companies, and CDMOs, delivering tailored technologies that accelerate the development and commercialization of groundbreaking therapies. Learn more at www.verdot-biotechnologies.com and follow VERDOT on LinkedIn.

About GMI

Founded in 1995, GMI provides new and certified pre-owned laboratory instruments, custom solutions, and service support to customers across the United States. Headquartered in Ramsey, Minnesota, GMI serves clients in academia, industry, and government, with a focus on reducing costs, extending the life of laboratory assets, and delivering personalized support. Learn more at www.gmi-inc.com.

Media Contact

VERDOT
Brian Gerwe
Sr. Director, Marketing and Product Management
[email protected]

GMI
Justin Volling
President & CEO
[email protected]